erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
.-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018.
.
.
orchid pharma faces liquidation as lenders reject resolution plan
.
the house has passed an order extending the public health committee's reporting deadline for cusack's bill.
.
despite travel warnings, mariah carey to still perform in indonesia
.
yesterday they welcomed the findings of coroner patrick mcgurgan, who criticised the staff caring for mrs cavanagh over a series of missed opportunities.
.
.
.
"smoking and drinking � giving these kids a little bit longer to make good decisions in their lives � i'm all for that," bruschi said.
.
.
.
.
.
the senate included a provision similar to cusack's bill in its omnibus health care overhaul legislation passed last november, according to sen.
.